ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,719,930 | -46.0% | 2,715,278 | -4.2% | 0.26% | -54.5% |
| Q2 2023 | $6,888,719 | -62.0% | 2,834,864 | -9.8% | 0.57% | -73.2% |
| Q1 2023 | $18,107,182 | -35.6% | 3,143,608 | 0.0% | 2.13% | -27.6% |
| Q4 2022 | $28,103,855 | -19.1% | 3,143,608 | +28.7% | 2.94% | -11.6% |
| Q3 2022 | $34,743,000 | -2.6% | 2,443,246 | -0.0% | 3.32% | -3.5% |
| Q2 2022 | $35,679,000 | +19.1% | 2,443,780 | +62.9% | 3.45% | +19.5% |
| Q1 2022 | $29,956,000 | – | 1,500,055 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |